The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...
But we have some pretty good clues. Among the possibilities: Newly empowered Republicans could tweak the Medicare drug price ...
The new structure includes the creation of a unified Human Foods Program, the adoption of a new model for the FDA's field ...